Shanghai’s food and drug administration is cooperating with health authorities to investigate the use of Avastin at local hospitals after 61 patients suffered adverse reactions to Avastin injections for macular degeneration and other eye disorders.
Though it is not officially approved for the treatment of macular degeneration, hospitals in many countries have used it on patients and consider it an effective treatment which is cheaper than officially approved medicine, according to insiders.
Li Weiping, deputy director of the Shanghai Health Bureau, said yesterday that the bureau is still investigating the cause of the eye infection which sickened dozens of patients at the Shanghai No. 1 People’s Hospital.
By yesterday morning, 61 patients were in hospital after adverse reactions from receiving Avastin injections.
A total of 116 patients received Avastin injections on Monday and Wednesday at the hospital.
All the 61 patients with adverse reactions like red eyes and poor vision were among the 116 patients receiving Avastin by two batches, Li said.